Table 1.

Primers

	Primer Sequence
β-Actin
Forward	5′-GTCCCTCACCCTCCCAAAAG-3′
Reverse	5′-GCTGCCTCAACACCTCAACCC-3′
AT1
Forward	5′-ATCGCTACCTGGCCATTGTC-3′
Reverse	5′-GGAAGCCCAGGATGTTCTTG-3′
AT2
Forward	F 5′-TTACCAGCAGCCGTCCTTTT-3′
Reverse	5′-GTCAGCCAAGGCCAGATTGA-3′
ET-1
Forward	5′-TCTTCCAGGTCCAAGCGTTC-3′
Reverse	5′-TGCTATTGCTGATGGCCTCC-3′
ETA
Forward	5′-TTGACCTCCCCATCAACGTG-3′
Reverse	5′-AGCACAGAGGTTCAAGACGG-3′
ETB
Forward	5′-CAAGGTCGCTCAGAAAACGC-3′
Reverse	5′-CCTAAACAGGCCTCTCGCAA-3′
NHE3
Forward	5′-GCCTTCATTCGCTCCCCAAGT-3′,
Reverse	5′-GAGATGCTTGTACTCCTGCCGA-3′.
NCC
Forward	5′-CCATTGGAAGGAAGGGGAAGTGC-3′
Reverse	5′-GTGCGTTCTGACTCTATCCCA-3′.
NKCC2
Forward	5′-GATGCAGAACTGGAAGCAGTCAA-3′
Reverse	5′-TCAGACACCAAGGCACAACATTT-3′
α-ENaC
Forward	5′-CGGGAAACGACCAAACGAAC-3′
Reverse	5′-CTTACTCTAGCCCCCACCCT-3′
β-ENaC
Forward	5′-TTGATGAGCGGAACCCTGAC3′
Reverse	5′-GGATTATGCGATCAGGGGCA3′
γ-ENaC
Forward	5′-CCTGGAGAGAAGATCAAAGCCA-3′
Reverse	5′-CCAAGTCAGTCAGGAGGTCAC-3′
IL-6
Forward	5′-CTCTGGGAAATCGTGGAAAT-3′,
Reverse	5′-CCAGTTTGGTAGCATCCATC-3′.
KC
Forward	5′-GCTGGGATTCACCTCAAGAA-3′,
Reverse	5′-TGGGGACACCTTTTAGCATC-3′.
TGF-β
Forward	5′-CCCTATATTTGGAGCCTGGA-3′,
Reverse	5′-CTTGCGACCCACGTAGTAGA-3′
TNF-α
Forward	5′-ATGAGAAGTTCCCAAATGGC-3′,
Reverse	5′-CTCCACTTGGTGGTTTGCTA-3′
INF-γ
Forward	5′-CGCTACACACTGCATCTTGG-3′,
Reverse	5′-GGCTGGATTCCGGCAACA-3′.
IL-17
Forward	5′-ATCAGGACGCGCAAACATG-3′,
Reverse	5′-TGATCGCTGCTGCCTTCAC-3′.
CCL2
Forward	5′-AGTTAACGCCCCACTCACCT-3′,
Reverse	5′-CCATTCCTTCTTGGGGTCAGC-3′
CCL5
Forward	5′-AGATCTCTGCAGCTGCCCTCA-3′,
Reverse	5′-GGAGCACTTGCTGCTGGTGTAG-3′

AT₁ and AT₂, angiotensin II receptors; ET, endothellin; NHE3, Na⁺/H⁺ exchanger 3; NCC, Na⁺-Cl⁻ cotransporter; NKCC2, Na⁺-K⁻-2Cl cotransporter 2; ENaC, epithelial Na⁺ channels; TGF-β, transforming growth factor-β; KC, keratinocyte-derived chemokine; CCL, chemokine (C-C motif) ligand.